PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 29, 2026Journal of Nanobiotechnology2 citationsOpen Access

Injectable ROS-scavenging and NIR-responsive nanocomposite hydrogel for staphylococcus aureus-infected diabetic wound healing

MCMing CaiZLZhao LiuXSXun Sun

Key Points

  • The research aims to develop a hydrogel that can treat chronic diabetic wounds impacted by infections and oxidative stress.
  • Synthesized hydrogel using dynamic boronate-ester crosslinking of poly(vinyl alcohol) and bis-boronic acid linker.
  • Incorporated PGS/MoS₂ nanocomposites to provide photothermal and photodynamic therapy.
  • Conducted in vitro tests to assess ROS scavenging, hyperthermic response, and antibacterial activity.
  • Evaluated wound healing efficacy in a diabetic mouse model.
  • The hydrogel effectively scavenged ROS and induced mild hyperthermia (~48 °C) under NIR light.
  • Demonstrated significant antibacterial activity against Staphylococcus aureus.
  • Achieved 46.7% residual wound area at day 7, compared to 66.5–92.4% in controls.
  • Almost complete wound healing was noted by day 14, with reduced bacterial load and inflammation.

Abstract

Abstract Chronic diabetic wounds are often complicated by persistent infections and oxidative stress, which impede effective healing. In this study, we developed an injectable, dual-responsive nanocomposite hydrogel designed to simultaneously scavenge reactive oxygen species (ROS) and deliver photothermal and photodynamic therapy for wound treatment. The hydrogel was synthesized via dynamic boronate-ester crosslinking of poly(vinyl alcohol) (PVA) with a bis-boronic acid linker (TSPBA), enabling efficient ROS quenching. Incorporation of palygorskite/molybdenum disulfide (PGS/MoS₂) nanocomposites imparted photothermal and photodynamic properties, activated by NIR light. In vitro tests demonstrated that the PVA-TSPBA@PGS/MoS₂ hydrogel effectively scavenged ROS, induced mild hyperthermia (~ 48 °C) under NIR, and exhibited significant antibacterial activity against Staphylococcus aureus. In vivo, the hydrogel accelerated wound closure in a diabetic mouse model, with a 46.7% residual area at day 7, compared to higher residual areas in control groups (66.5–92.4%). By day 14, nearly complete wound healing was achieved, accompanied by reduced bacterial load and inflammatory markers, as well as enhanced re-epithelialization, angiogenesis, and collagen remodeling. These findings suggest that this multifunctional hydrogel represents a promising strategy for the treatment of infected diabetic wounds, offering a controlled, localized approach to wound healing. Graphical Abstract

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cai et al. (2026) studied this question.

synapsesocial.com/papers/69c8c25dde0f0f753b39cb07https://doi.org/10.1186/s12951-026-04306-4
Ask AI
Helpful
Bookmark
Share
View Full Paper